Jan 28, 2025 · The global cell and gene therapy market was projected to reach €1.8 billion in 2021, with North America as the dominant region, housing over 400 companies and controlling 60% of the market share in 2018. Europe and the Asia-Pacific (APAC) regions followed as significant players in the market.

Apr 17, 2024 · This article outlines key FDA regulatory developments from the past few months relevant to sponsors seeking approval of cell and gene therapies in the U.S.

Set Your Cell And Gene Therapy Program Up For Success From Day One Partner with a specialized CDMO early in your CGT development to ensure a streamlined path from discovery to successful commercialization, avoiding costly pitfalls and delays.

Feb 9, 2024 · This article discusses the 2024 state of the macroeconomy, its effects on cell and gene therapy companies, growing approval pipelines and approvals, funding factors, and the unique prospects for the market.

Jan 30, 2025 · This article explores the rapid evolution of cell and gene therapy (CGT), highlighting its expansion beyond hematology and oncology into autoimmune and metabolic diseases, emphasizing the need for safety, patient access, and a collaborative, knowledge-sharing approach to accelerate innovation and ensure broader therapeutic impact via the ...

Nov 25, 2024 · Critical starting materials, such as plasmid DNA, play a pivotal role in advancing cell and gene therapy, regenerative medicine, and vaccine development. Ensuring their quality and consistency is vital for achieving long-term clinical success.

Jan 16, 2025 · Cell & gene therapy companies are required by regulation to qualify sites performing all the steps and methods as part of their manufacturing processes.

Dec 4, 2024 · The cell and gene therapy sector is poised for significant advancements in 2025 driven by three key trends: an expanding focus on non-oncology indications, the development of more precise gene-editing technologies, and the pursuit of scalable manufacturing solutions.

Hear from experts in the cell and gene therapy space about their shared insights into potential trends driving the future of allogeneic therapies for oncology.

Cell & Gene, the most valuable resource for delivering in-depth content from authoritative authors and sources to professionals in the CGT sector, brings you Cell & Gene: The Podcast. Each episode explores approved and pipeline therapies, new trends in manufacturing, the long, regulated road to commercialization, and everything in between.